Pricing

Armata Pharmaceuticals Inc (ARMP)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Brian C. Varnum
Employees:
70
5005 MCCONNELL AVE, LOS ANGELES, CA, 90066
310-665-2928
    Formally known as:
  • Amplphi Biosciences Corp.
  • ARMATA PHARMACEUTICALS ORD SHS
Stock Split History
DateRatio
2015-08-07 1:50
2017-04-25 1:10
2019-05-10 1:14
Armata Pharmaceuticals, Inc. focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PS03 for pneumonia.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available